Zai Lab (ZLAB) EBIT (2018 - 2026)

Zai Lab has reported EBIT for 9 years, with the latest figure at -$69.4 million in Q1 2026.

• Quarterly EBIT fell 23.22% year-over-year to -$69.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$242.5 million (up 9.55% YoY) and the FY2025 annual result came in at -$229.4 million, up 18.67% from the prior year.
• EBIT was little changed at -$69.4 million in Q1 2026 per ZLAB's latest filing, from -$69.4 million in the prior quarter.
• Over five years, EBIT peaked at -$48.8 million in Q3 2025 and troughed at -$128.6 million in Q3 2022.
• A 5-year average of -$79.5 million and a median of -$70.3 million in 2024 frame the typical range for EBIT.
• The widest YoY moves for EBIT: up 64.88% in 2022, down 54.54% in 2022.
• Over 5 years, EBIT stood at -$97.3 million in 2022, then declined by 27.43% to -$124.0 million in 2023, then jumped by 45.24% to -$67.9 million in 2024, then slipped by 2.23% to -$69.4 million in 2025, then increased by 0.03% to -$69.4 million in 2026.
• According to Business Quant data, EBIT over the past three periods registered -$69.4 million, -$69.4 million, and -$48.8 million for Q1 2026, Q4 2025, and Q3 2025 respectively.